IGF-1-based screening reveals a low prevalence of acromegaly in patients with obstructive sleep apnea
Tóm tắt
Recent epidemiologic studies suggest a high prevalence of acromegaly. The prevalence of obstructive sleep apnea syndrome (OSAS) in acromegaly patients ranges from 47 to 70%. A recent study identified 2 patients with acromegaly among 567 OSAS patients. However, it remains unclear whether screening for acromegaly among OSAS patients is necessary. The aim was to screen for acromegaly among OSAS patients by measuring IGF-1 levels and performing confirmatory tests if necessary. We performed a prospective cross-sectional diagnostic study on the prevalence of acromegaly in patients with OSAS. A total of 507 patients with a confirmed diagnosis of OSAS (357 male, 150 female) were screened. Seven male and three female patients (1.97% of total) were positively screened for elevated IGF-1 levels. Nine out of ten patients suppressed growth hormone levels during OGTT excluding acromegaly, whereas one individual was identified to have acromegaly according to established criteria (1/507, prevalence 0.2%). Analysis of the data showed no correlation between elevated IGF-1 values and the severity of OSAS or BMI. Our data demonstrate a low prevalence of acromegaly in patients with OSAS. Until data from population-based studies is available we suggest restricting screening for acromegaly in OSAS to those patients who have additional clinical features of acromegaly.
Tài liệu tham khảo
S. Melmed, Medical progress: acromegaly. N. Engl. J. Med. 355(24), 2558–2573 (2006). https://doi.org/10.1056/NEJMra062453
J. Etxabe, S. Gaztambide, P. Latorre, J.A. Vazquez, Acromegaly: an epidemiological study. J. Endocrinol. Invest. 16(3), 181–187 (1993)
I.M. Holdaway, C. Rajasoorya, Epidemiology of acromegaly. Pituitary 2(1), 29–41 (1999)
A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769–4775 (2006). https://doi.org/10.1210/jc.2006-1668
A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72(3), 377–382 (2010). https://doi.org/10.1111/j.1365-2265.2009.03667.x
G.T. Hoskuldsdottir, S.B. Fjalldal, H.A. Sigurjonsdottir, The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary 18(6), 803–807 (2015). https://doi.org/10.1007/s11102-015-0655-4
A. Lavrentaki, A. Paluzzi, J.A. Wass, N. Karavitaki, Epidemiology of acromegaly: review of population studies. Pituitary 20(1), 4–9 (2017). https://doi.org/10.1007/s11102-016-0754-x
H.J. Schneider, C. Sievers, B. Saller, H.U. Wittchen, G.K. Stalla, High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin. Endocrinol. 69(3), 432–435 (2008). https://doi.org/10.1111/j.1365-2265.2008.03221.x
M.S. Broder, M.P. Neary, E. Chang, D. Cherepanov, L. Katznelson, Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases. Pituitary 17(4), 333–341 (2014). https://doi.org/10.1007/s11102-013-0506-0
A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004). https://doi.org/10.1210/er.2002-0022
S. Melmed, F.F. Casanueva, A. Klibanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A. Wass, A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3), 294–302 (2013). https://doi.org/10.1007/s11102-012-0420-x
P. Attal, P. Chanson, Endocrine aspects of obstructive sleep apnea. J. Clin. Endocrinol. Metab. 95(2), 483–495 (2010). https://doi.org/10.1210/jc.2009-1912
E. Kuhn, L. Maione, A. Bouchachi, M. Roziere, S. Salenave, S. Brailly-Tabard, J. Young, P. Kamenicky, P. Assayag, P. Chanson, Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study. Eur. J. Endocrinol. 173(5), 693–702 (2015). https://doi.org/10.1530/EJE-15-0500
L.M. Fatti, M. Scacchi, A.I. Pincelli, E. Lavezzi, F. Cavagnini, Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4(4), 259–262 (2001)
M.V. Davi, L. Dalle Carbonare, A. Giustina, M. Ferrari, A. Frigo, V. Lo Cascio, G. Francia, Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur. J. Endocrinol. 159(5), 533–540 (2008). https://doi.org/10.1530/EJE-08-0442
P. Petrossians, A.F. Daly, E. Natchev, L. Maione, K. Blijdorp, M. Sahnoun-Fathallah, R. Auriemma, A.M. Diallo, A.L. Hulting, D. Ferone, V. Hana Jr., S. Filipponi, C. Sievers, C. Nogueira, C. Fajardo-Montanana, D. Carvalho, V. Hana, G.K. Stalla, M.L. Jaffrain-Rea, B. Delemer, A. Colao, T. Brue, S. Neggers, S. Zacharieva, P. Chanson, A. Beckers, Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocr. Relat. Cancer 24(10), 505–518 (2017). https://doi.org/10.1530/ERC-17-0253
R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115(7), 527–532 (1991)
L.M. Galerneau, J.L. Pepin, A.L. Borel, O. Chabre, M. Sapene, B. Stach, J. Girey-Rannaud, N. Arnol, R. Tamisier, P. Caron; scientific council, investigators of the French national sleep apnoea registry, Acromegaly in sleep apnoea patients: a large observational study of 755 patients. Eur. Respir. J. 48(5), 1489–1492 (2016). https://doi.org/10.1183/13993003.01229-2016
G. Sesmilo, E. Resmini, M. Sambo, C. Blanco, F. Calvo, F. Pazos, P. Fernandez-Catalina, P. Martinez de Icaya, C. Paramo, C. Fajardo, M. Marazuela, C. Alvarez-Escola, J.J. Diez, V. Perea; group, A.s., Prevalence of acromegaly in patients with symptoms of sleep apnea. PLoS. ONE. 12(9), e0183539 (2017). https://doi.org/10.1371/journal.pone.0183539
W. Lee, S. Nagubadi, M.H. Kryger, B. Mokhlesi, Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev. Respir. Med. 2(3), 349–364 (2008). https://doi.org/10.1586/17476348.2.3.349
L.J. Epstein, D. Kristo, P.J. Strollo Jr., N. Friedman, A. Malhotra, S.P. Patil, K. Ramar, R. Rogers, R.J. Schwab, E.M. Weaver, M.D. Weinstein; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine, Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep. Med. 5(3), 263–276 (2009).
C.L. Rosen, D. Auckley, R. Benca, N. Foldvary-Schaefer, C. Iber, V. Kapur, M. Rueschman, P. Zee, S. Redline, A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. Sleep 35(6), 757–767 (2012). https://doi.org/10.5665/sleep.1870
M. Bidlingmaier, N. Friedrich, R.T. Emeny, J. Spranger, O.D. Wolthers, J. Roswall, A. Korner, B. Obermayer-Pietsch, C. Hubener, J. Dahlgren, J. Frystyk, A.F. Pfeiffer, A. Doering, M. Bielohuby, H. Wallaschofski, A.M. Arafat, Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J. Clin. Endocrinol. Metab. 99(5), 1712–1721 (2014). https://doi.org/10.1210/jc.2013-3059
D.R. Clemmons, Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin. Chem. 57(4), 555–559 (2011). https://doi.org/10.1373/clinchem.2010.150631
P.U. Freda, C.M. Reyes, A.T. Nuruzzaman, R.E. Sundeen, J.N. Bruce, Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly. Pituitary 6(4), 175–180 (2003)
J. Manolopoulou, Y. Alami, S. Petersenn, J. Schopohl, Z. Wu, C.J. Strasburger, M. Bidlingmaier, Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin. Chem. 58(10), 1446–1456 (2012). https://doi.org/10.1373/clinchem.2012.188128
M. Reincke, S. Petersenn, M. Buchfelder, B. Gerbert, G. Skrobek-Engel, H. Franz, R. Lohmann, H.J. Quabbe, The German acromegaly registry: description of the database and initial results. Exp. Clin. Endocrinol. Diabetes 114(9), 498–505 (2006). https://doi.org/10.1055/s-2006-948313
J. Roemmler, B. Gutt, R. Fischer, S. Vay, A. Wiesmeth, M. Bidlingmaier, J. Schopohl, M. Angstwurm, Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity. Sleep. & breathing = Schlaf & Atm. 16(4), 1247–1253 (2012). https://doi.org/10.1007/s11325-011-0641-7
H.J. Schneider, B. Saller, J. Klotsche, W. Marz, W. Erwa, H.U. Wittchen, G.K. Stalla, Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur. J. Endocrinol. 154(5), 699–706 (2006). https://doi.org/10.1530/eje.1.02131